-
Covaxin, along with Covishield manufactured by Serum Institute of India, are the two vaccines so far being used in India's current COVID-19 vaccination drive
-
The survey suggested that the neutralising antibodies declined significantly after five-six months, making people prone to reinfections
-
A year later, what has changed? Even though we have vaccines that are reasonably effective
against the virus, the second wave has hit us much harder
-
Ports Ministry will monitor the details of such vessels, cargo and time taken in the port from the time vessel entered in the port limits to exit of cargo from port gate
-
These dedicated plants will be established in identified government hospitals in district headquarters in various states and union territories.
-
Delhi recorded the highest single-day rise in its COVID-19 death toll with 357 more people succumbing to the viral disease on Saturday
-
Majority of the Indian twitter users have expressed their anger on social media over variation in the costs of vaccine set for people.
-
The active cases have increased to 26,82,751 comprising 15.82 per cent of the total infections, while the national COVID-19 recovery rate has further dropped to 83.05 per cent
-
The data of the last 24 hours also revealed that the number of active coronavirus cases in the national capital is inching closer to the one-lakh mark
-
"We would like to state that more than 50% of our capacities have been reserved for central government supplies," said Krishna M Ella, Bharat Biotech Chairman and Managing Director
